Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
severely red about the size of a baseball injection site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. In MAY-2025, the patient received Shingles vaccine. In MAY-2025, an unknown time after receiving Shingles vaccine, the patient experienced injection site erythema (Verbatim: severely red about the size of a baseball injection site). The outcome of the injection site erythema was not reported. It was unknown if the reporter considered the injection site erythema to be related to Shingles vaccine. It was unknown if the company considered the injection site erythema to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 16-MAY-2025 The case was received from the patient via (Shringrix GSK Chatbot) interactive digital media. The reporter got a shingle shot 3 days before reporting and it was red severely red about the size of a baseball injection site.